Glucokinase Activator-based Solutions for Diverse Industries

Publication ID: 24-11857536_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Glucokinase Activator-based Solutions for Diverse Industries,” Published Technical Disclosure No. 24-11857536_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857536_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,536.

Summary of the Inventive Concept

This inventive concept expands the application of glucokinase activators beyond diabetes treatment to address pressing challenges in agriculture, livestock, environmental monitoring, animal health, and human performance.

Background and Problem Solved

The original patent focused on treating diabetes in renally impaired subjects using glucokinase activators. However, the limitations of this approach become apparent when considering the broader potential of glucokinase activators in addressing various industries' unmet needs. This inventive concept addresses these limitations by exploring new applications and use cases for glucokinase activators.

Detailed Description of the Inventive Concept

The inventive concept comprises a system for predicting and preventing agricultural crop failures by leveraging glucokinase activators to enhance soil moisture sensing. Additionally, it includes a method for optimizing livestock feed formulations using glucokinase activators to improve nutrient uptake in animals with impaired renal function. Furthermore, it encompasses a device for monitoring and controlling water quality in aquatic ecosystems, utilizing glucokinase activators to detect changes in water pH levels. The inventive concept also involves a method for treating and preventing neurological disorders in animals by administering glucokinase activators to enhance cognitive function and memory. Lastly, it incorporates a system for improving exercise performance in athletes, combining glucokinase activators with wearable devices for monitoring physiological parameters.

Novelty and Inventive Step

The new claims introduce a paradigm shift in the application of glucokinase activators, moving beyond diabetes treatment to tackle diverse industry-specific challenges. The inventive step lies in recognizing the potential of glucokinase activators to address unmet needs in agriculture, livestock, environmental monitoring, animal health, and human performance.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using glucokinase activators in precision agriculture for real-time soil monitoring, developing personalized livestock feed formulations based on individual animal needs, or creating implantable devices for continuous water quality monitoring. Variations could also involve adapting the glucokinase activator-based system for monitoring and controlling air quality or using it in bioremediation applications.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in various industries, including agriculture, livestock, environmental monitoring, animal health, and human performance. The target market includes companies developing precision agriculture solutions, livestock feed manufacturers, environmental monitoring organizations, animal health companies, and sports technology firms.

Original Patent Information

Patent NumberUS 11,857,536
TitleGlucokinase activator for treating diabetes with renal impairment
Assignee(s)HUA Medicine (Shanghai) Ltd.